ITGA1 and hepatocellular carcinoma: Accumulation of CD49a+ NK cells in the human liver indicates deteriorating disease condition and poor prognosis and thus elimination of CD49a+ NK cells could represent a potential therapeutic strategy in the immunotherapy of HCC [81].